Evidence of Omics, Immune Infiltration, and Pharmacogenomic for SENP1 in the Pan-Cancer Cohort
Sentrin specific-protease 1 (SENP1) is a protein involved in deSUMOylation that is almost overexpressed in cancer. SENP1 has a determinative role in the activation of transcription programs in the innate immune responses and the development B of and C lymphocytes. We found, SENP1 possibly plays a cr...
Main Authors: | Somayye Taghvaei, Farzaneh Sabouni, Zarrin Minuchehr |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2021-07-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | https://www.frontiersin.org/articles/10.3389/fphar.2021.700454/full |
Similar Items
-
Currently Available Non-Balloon Devices
by: Hang Lak Lee
Published: (2018-09-01) -
Neuronal Localization of SENP Proteins with Super Resolution Microscopy
by: Luca Colnaghi, et al.
Published: (2020-10-01) -
Fragility of randomized trials supporting cancer drug approvals stratified by approval pathway and review designations
by: Brooke E. Wilson, et al.
Published: (2021-08-01) -
Drugs and Devices
by: Gail A. Van Norman, MD
Published: (2016-08-01) -
Advances in the development of SUMO specific protease (SENP) inhibitors
by: Ashutosh Kumar, et al.
Published: (2015-01-01)